{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:25:50Z","timestamp":1793384750076,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>There is renewed interest in subretinal drug delivery as the result of novel and emerging treatments for retinal diseases, including retinal gene therapy. However, our knowledge of the distribution of subretinally delivered drugs is incomplete; herein, we describe a qualitative and quantitative means of surveying the early intraocular distribution of subretinally delivered drugs using dilute sodium fluorescein (NaFl).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Sodium fluorescein 10% was serially diluted and mixed with a solution containing tissue plasminogen activator (tPA) at a final concentration of 0.1 mg\/mL NaFl and 0.5 mg\/mL of tPA. Because this solution was to be used in the context of subretinal tPA injection in the treatment of subretinal hemorrhage, fluorophotometry with, and without, the presence of human whole blood was performed to derive a formula to calculate the concentration of NaFl based on the fluorescence of aspirated intraocular fluid. Videos of subretinal tissue plasminogen activator surgery in a case are presented as a qualitative demonstration of the technique and vitreous cavity fluid collected at case completion underwent fluorophotometry to estimate the loss of therapeutic solution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Although the presence of hemoglobin in blood suppresses fluorescence of NaFl, we demonstrate that centrifuging admixtures of blood with NaFl negates the optical effects of blood and yields identical fluorescence versus concentration plots to those of NaFl solution alone. We also demonstrate that NaFl at 0.1 mg\/mL can be readily used to qualitatively assess drug losses before, during, and after subretinal injection. Furthermore, we describe how it may be used to quantitatively estimate the total loss of therapeutic solution during subretinal injection using fluorophotometry on aspirated fluid from the vitreous cavity (loss estimated as 4% in the case presented).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Sodium fluorescein at a concentration of 0.1 mg\/mL can be used to quantitatively and qualitatively assess the fate of subretinally injected drugs during subretinal injection surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002800","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T06:13:16Z","timestamp":1586412796000},"page":"158-161","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Sodium Fluorescein as an Optical Label to Evaluate Subretinal Injection"],"prefix":"10.1097","volume":"43","author":[{"given":"Matthew P.","family":"Simunovic","sequence":"first","affiliation":[{"name":"Save Sight Institute, University of Sydney, Sydney, NSW, Australia;"},{"name":"Sydney Eye Hospital, Sydney, NSW, Australia; and"},{"name":"Nuffield Laboratory of Ophthalmology, John Radcliffe Hospital, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perach","family":"Osaadon","sequence":"additional","affiliation":[{"name":"Save Sight Institute, University of Sydney, Sydney, NSW, Australia;"},{"name":"Sydney Eye Hospital, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Khoon","family":"Too","sequence":"additional","affiliation":[{"name":"Save Sight Institute, University of Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamaophthalmol.2016.5630","article-title":"Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy","volume":"135","author":"Simunovic","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.survophthal.2015.04.004","article-title":"Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature","volume":"61","author":"Stanescu-Segall","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia","volume":"374","author":"Edwards","year":"2016","journal-title":"N Engl J Med"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/IAE.0000000000001349","article-title":"Fluorescein-assisted subretinal tissue plasminogen activator (tPA) delivery for submacular hemorrhage","volume":"37","author":"Khan","year":"2017","journal-title":"Retina"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.6.4.4","article-title":"Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in vitro and in vivo analysis","volume":"6","author":"Salvetti","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-3806(83)90211-0","article-title":"Effect of sodium fluorescein on neurite outgrowth from the retinal explant culture: an in vitro model for retinal toxicity","volume":"313","author":"Kato","year":"1983","journal-title":"Brain Res"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9394(14)72259-7","article-title":"Tissue plasminogen activator treatment of experimental subretinal hemorrhage","volume":"111","author":"Lewis","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"e0136523","DOI":"10.1371\/journal.pone.0136523","article-title":"Trans-corneal subretinal injection in mice and its effect on the function and morphology of the retina","volume":"10","author":"Qi","year":"2015","journal-title":"PLoS One"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"e0156542","DOI":"10.1371\/journal.pone.0156542","article-title":"Effects of subretinal gene transfer at different time points in a mouse model of retinal degeneration","volume":"11","author":"Dai","year":"2016","journal-title":"PLoS One"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.7.2.19","article-title":"Volumetric measurement of subretinal blebs using microscope-integrated optical coherence tomography","volume":"7","author":"Hsu","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1167\/iovs.10-6720","article-title":"Integration of a spectral domain optical coherence tomography system into a surgical microscope for intraoperative imaging","volume":"52","author":"Ehlers","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:05:51Z","timestamp":1749143151000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002800","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}